Quick facts for Australia
- Mounjaro is tirzepatide, a weekly dual-agonist (GLP-1 + GIP) injection used in metabolic care.
- In Australia, tirzepatide is TGA-approved for type 2 diabetes. A tirzepatide brand is also approved for chronic weight management. Availability and supply can vary.
- Prescription only (Schedule 4). You need assessment by an Australian-registered prescriber.
- Private prices differ by dose, brand and pharmacy. See detailed ranges: Mounjaro Cost Australia.
- PBS settings can change. Ask your clinician/pharmacist or check the official PBS schedule.
- Not for type 1 diabetes. Important contraindications and warnings apply (see safety section).
What is Mounjaro (tirzepatide) and how it works
Mounjaro is the brand name for tirzepatide, a once-weekly injectable medicine that activates two incretin pathways: GLP-1 and GIP. By stimulating both receptors, tirzepatide can reduce appetite, slow gastric emptying, and improve insulin secretion and sensitivity. In clinical trials, people using tirzepatide experienced substantial reductions in blood glucose (type 2 diabetes) and meaningful body weight reductions when used as part of a comprehensive plan that includes diet and physical activity.
- Dual-agonist mechanism: GLP-1 + GIP
- Weekly dosing via a pre-filled injection pen
- Typical titration: start low and step up gradually to improve tolerability
Considering tirzepatide vs single-agonist GLP-1s? See our comparisons: Mounjaro vs Ozempic, Mounjaro vs Wegovy and Semaglutide vs Tirzepatide.
Is Mounjaro available in Australia right now?
Yes, with conditions. Tirzepatide (Mounjaro) is TGA-approved in Australia for type 2 diabetes. A tirzepatide brand is also approved for chronic weight management. In practice, availability and pharmacy stock can fluctuate due to high demand and global supply.
- Prescription required: Australian-registered prescriber assessment is mandatory.
- Pharmacy supply: Your local or online Australian pharmacy may need to order stock. Expect wait times if demand is high.
- Avoid overseas websites: Importing prescription medicines without proper authority risks seizure and safety issues.
Who it may be suitable for in Australia
Eligibility is assessed individually. Broad patterns include:
- Type 2 diabetes: Adults where tirzepatide is clinically appropriate to improve glycaemic control.
- Chronic weight management: Adults meeting BMI and comorbidity criteria for the approved tirzepatide weight-management indication. Your prescriber will confirm if you qualify and which brand is suitable.
Not suitable for everyone. People with a personal/family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) should not use tirzepatide. It is not for type 1 diabetes or for use in pregnancy or while breastfeeding. Your clinician will review your medical history and current medicines.
How to access Mounjaro in Australia
- Clinical assessment: Book with a GP, endocrinologist, obesity physician or a compliant telehealth clinic. Discuss goals, history, current meds and risks.
- Prescription: If appropriate, your prescriber issues an Australian prescription specifying brand/strength and repeats.
- Pharmacy dispensing: Take your script to an Australian pharmacy. They may order stock and advise on current supply and price at your dose.
- Follow-up care: Dose titration, side-effect management, monitoring of glucose (if diabetic) and broader metabolic risk factors are important for safety and outcomes.
Be cautious about unregulated online sellers, social media offers or “no-prescription” sites. Counterfeit and mislabelled products are common, and importing prescription medicines without authority can breach Australian law.
Typical dosing and titration
Your prescriber will set a plan for you. A common pattern is weekly injections starting at a low dose and stepping up to reduce gastrointestinal side effects:
- Start: 2.5 mg once weekly
- Step-ups: 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg once weekly as tolerated
Do not change your dose without medical advice. If you miss a dose, follow the product guidance or ask your pharmacist/clinician what to do next.
Cost, PBS status and supply notes
Private price: Costs vary by strength and pharmacy. Starting doses are usually cheaper than higher-dose pens. Some clinics add consult and follow-up fees. See indicative ranges and what drives price here: Mounjaro Cost Australia.
PBS: PBS listings can change and may differ by indication. Many weight-management uses are private. If you have type 2 diabetes, ask your clinician and pharmacist whether any current PBS listing applies to your circumstances.
Supply: Demand surges can cause intermittent shortages. Pharmacies may place you on order lists or suggest equivalent brands if clinically suitable. Plan ahead for repeats.
Side effects and key warnings
Common effects include nausea, vomiting, diarrhoea, constipation, abdominal pain, reduced appetite and fatigue, especially during dose increases. Many settle with time and supportive care, but you should report persistent or severe symptoms.
Serious warnings (seek medical advice promptly):
- Pancreatitis: severe, persistent abdominal pain (with/without vomiting)
- Gallbladder problems: right-upper abdominal pain, fever, jaundice
- Kidney issues from dehydration: especially if vomiting/diarrhoea is significant
- Diabetic retinopathy changes: in people with diabetes; report vision symptoms
- Hypoglycaemia: risk increases when used with insulin or sulfonylureas
Contraindicated in patients with a personal/family history of medullary thyroid carcinoma (MTC) or MEN2. Not for type 1 diabetes. Not recommended in pregnancy or breastfeeding. Review the Consumer Medicine Information (CMI) and Product Information (PI) and discuss risks, interactions and monitoring with your clinician.
Learn more detail: Mounjaro Side Effects
How Mounjaro compares to other Australian options
- Mounjaro vs Ozempic: dual agonist vs GLP-1 only, dose range, outcomes, cost
- Mounjaro vs Wegovy: titration, weight loss data, side-effect profiles
- Semaglutide vs Tirzepatide: head-to-head considerations for weight loss goals
- Broader overview: Weight Loss Injections Australia and GLP-1 Australia Guide
Frequently asked questions
Is Mounjaro legal to buy in Australia?
Yes, with a valid Australian prescription. Pharmacies dispense it locally. Buying without a script or importing without authority risks seizure and safety issues.
Can I use Mounjaro for weight loss in Australia?
A tirzepatide brand is approved for chronic weight management in Australia. Your clinician will confirm which brand/indication fits your circumstances and whether you meet criteria.
How long until I notice effects?
Appetite changes can occur within weeks, often after initial dose steps. Weight and glucose changes are typically evaluated over months alongside lifestyle changes and follow-up care.
What if my pharmacy is out of stock?
Ask to be placed on order lists, check other local/online Australian pharmacies, and plan repeats early. Your prescriber may advise alternatives if appropriate.
Do I need regular check-ins?
Yes. Titration, side-effect review, and monitoring of glucose (if diabetic), kidney function and other risk factors help improve outcomes and safety.
Where can I see pricing details?
See our pricing breakdown here: Mounjaro Cost Australia. Your pharmacy can provide current dose-specific quotes.
Speak with an Australian provider
Answer a few quick questions and we’ll connect you with a compliant Australian prescriber or clinic for guidance on eligibility, access, dosing and costs.
Prefer email? Contact us
Key takeaways
- Tirzepatide (Mounjaro) is available in Australia under prescription, with approvals that differ by indication.
- Costs vary by dose and pharmacy; PBS settings change over time—verify for your situation.
- Safety matters: get proper assessment, titrate gradually and attend follow-up reviews.
- Compare options like Ozempic and Wegovy with a clinician to match your goals and budget.